Literature DB >> 10355195

Lingual thyroid gland: clinical evaluation and comprehensive management.

A Kalan1, M Tariq.   

Abstract

Although lingual thyroid gland is the most common benign mass found at the junction of the anterior two-thirds and the posterior one-third of the tongue, it is still a rare clinical entity. This developmental anomaly is the result of an arrested descent of the gland anlage early in the course of embryogenesis. Patients may have symptoms of dysphagia due to obstruction or even hemorrhage. These symptoms can occur at any time from infancy through adulthood. The clinical findings, laboratory tests, and radiographic imaging studies employed in confirming the diagnosis and in planning appropriate treatment have been evaluated. The primary therapeutic goal is to restore thyroid function. We describe a case of lingual thyroid gland and summarize the current management principles for this condition.

Entities:  

Mesh:

Year:  1999        PMID: 10355195

Source DB:  PubMed          Journal:  Ear Nose Throat J        ISSN: 0145-5613            Impact factor:   1.697


  5 in total

1.  Clinical pathologic conference case 4: hylanizing clear cell carcinoma.

Authors:  Darren Cox; Christel Haberland
Journal:  Head Neck Pathol       Date:  2011-08-23

2.  Transoral robot-assisted excision of a lingual thyroid gland.

Authors:  James T May; Jason G Newman; Tapan A Padhya
Journal:  J Robot Surg       Date:  2011-02-23

3.  Ectopic Intratracheal Thyroid: A Rare Cause of Airway Obstruction.

Authors:  Waheed Rahman; Nafil Ishaq Arimbrathodi; Faisal Abdulkader; Hussain Al-Enazi; Zeynel A Dogan
Journal:  Case Rep Otolaryngol       Date:  2018-01-27

4.  Ectopic lingual goiter treated by transoral robotic surgery.

Authors:  R Pellini; G Mercante; P Ruscito; G Cristalli; G Spriano
Journal:  Acta Otorhinolaryngol Ital       Date:  2013-10       Impact factor: 2.124

5.  New insight into ectopic thyroid glands between the neck and maxillofacial region from a 42-case study.

Authors:  Ting Gu; Boren Jiang; Ningjian Wang; Fangzhen Xia; Lizhen Wang; Aichun Gu; Feng Xu; Yongshun Han; Qin Li; Yingli Lu
Journal:  BMC Endocr Disord       Date:  2015-11-18       Impact factor: 2.763

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.